Skip to main content
padlock icon - secure page this page is secure

Open Access Is Switzerland Still a Lucrative Place for Manufacturers of Drug Substances to Produce Their Products?

Download Article:
 Download
(PDF 1,105.9 kb)
 
Pharmaceutical manufacturers are coming under increasing pricing pressure as a result of healthcare reforms and are therefore looking to low wage countries in the Far East. Often, the outcome is a process that is not fully mature in economic terms. Contract synthesis manufacturers, such as Siegfried, offer assistance here with its comprehensive pharmaceutical know-how in order to establish efficient and low-cost processes at an early stage. Siegfried's strengths lie in its many years experience in the pharmaceutical industry and in the network of contacts it has built up over the years with technical and material suppliers. Therefore, as far as Switzerland as a location for manufacturing is concerned, Siegfried looks to the future with confidence.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: API MANUFACTURER; CHINA; HEALTHCARE REFORM; PRICING PRESSURE; SIEGFRIED; SWITZERLAND

Document Type: Research Article

Publication date: January 1, 2005

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more